These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Lost in the labyrinth of end points. Lipworth BJ Chest; 2001 Jul; 120(1):323-4. PubMed ID: 11451868 [No Abstract] [Full Text] [Related]
25. Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma. Pelaia G; Vatrella A; Busceti MT; Fabiano F; Terracciano R; Matera MG; Maselli R Pulm Pharmacol Ther; 2016 Oct; 40():15-21. PubMed ID: 27381656 [TBL] [Abstract][Full Text] [Related]
26. Role of budesonide inhalation suspension in children with asthma. West KM; Culhane NS Ann Pharmacother; 2002 Feb; 36(2):322-5. PubMed ID: 11847955 [TBL] [Abstract][Full Text] [Related]
27. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. Tsai YG; Lee MY; Yang KD; Chu DM; Yuh YS; Hung CH J Pediatr; 2001 Sep; 139(3):433-7. PubMed ID: 11562625 [TBL] [Abstract][Full Text] [Related]
37. Refractory asthma coexisting with a double aortic arch: a case report and literature review. Yang HJ; Pyun BY J Asthma; 2010 Dec; 47(10):1165-7. PubMed ID: 20946085 [TBL] [Abstract][Full Text] [Related]
38. [Clinicomorphological assessment of budesonide efficiency in patients with bronchial asthma]. Budkova AA; Volkova LI; Budkov SR; Bogomiagkov VS Ter Arkh; 2003; 75(8):48-51. PubMed ID: 14520851 [TBL] [Abstract][Full Text] [Related]
40. Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy. Santus P; Giovannelli F; Di Marco F; Centanni S Expert Opin Pharmacother; 2010 Feb; 11(2):257-67. PubMed ID: 20088747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]